Sign In
Buy GOVX
$1.32
-0.0200 (-1.49%)
At Close: Jun 22, 2026
GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
10:56am, Friday, 12'th Jun 2026
GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wa
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox Transcript
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats
02:07pm, Wednesday, 20'th May 2026
GeoVax Labs, Inc. (NASDAQ:GOVX), a clinical-stage biotech company, is trading higher on Wednesday as investors assess the company's recent financing deal alongside growing attention on its vaccine pla
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy
01:01pm, Friday, 15'th May 2026
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy?
02:10am, Saturday, 03'rd Jan 2026
GeoVax Labs Inc. (NASDAQ: GOVX - Get Free Report) was up 21.1% on Friday. The company traded as high as $0.2105 and last traded at $0.2070. Approximately 6,520,937 shares changed hands during mid-day
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript
10:41pm, Thursday, 13'th Nov 2025
GeoVax Labs, Inc. ( GOVX ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants David Dodd - Chairman, President & CEO Mark Reynolds - CFO & Corporate Secretary John Sharkey - Vice
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 20'th Aug 2025
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GeoVax Labs Revenue Doubles in Q2
06:34am, Tuesday, 29'th Jul 2025
GeoVax Labs Revenue Doubles in Q2
GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript
07:43pm, Monday, 28'th Jul 2025
GeoVax Labs, Inc. (NASDAQ:GOVX ) Q2 2025 Earnings Conference Call July 28, 2025 4:30 PM ET Company Participants David Alan Dodd - Chairman, President & CEO John W. Sharkey - Vice President of Business
GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript
08:58pm, Thursday, 01'st May 2025
GeoVax Labs, Inc. (NASDAQ:GOVX ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Max Gadicke - Precision AQ, Investor Relations David Dodd - Chairman, President & Chief Ex
GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital
10:12am, Tuesday, 15'th Apr 2025
D. Boral Capital lowered the firm's price target on GeoVax Labs to $14 from $18 and keeps a Buy rating on the shares. GeoVax has encountered a significant challenge following the termination of its BA
GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript
08:53pm, Thursday, 27'th Mar 2025
GeoVax Labs, Inc. (NASDAQ:GOVX ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Max Gadicke - Precision AQ, Investor Relations David Dodd - Chairman, President & CEO M
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
09:00am, Monday, 09'th Dec 2024
Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vacci
3 Penny Stocks Ready to Break Out in 2025
08:02am, Friday, 29'th Nov 2024
Known for their uncommonly pronounced risk/reward profile, penny stocks all too often entice investors with their low prices and potential for significant returns, only to fail to live up to those exp
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
09:00am, Tuesday, 26'th Nov 2024
ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chai
